MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$986K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Maturities of available-for-sale...
Stock-based compensation
Other income, net
Others
Negative Cash Flow Breakdown
Purchases of available-for-sale ...
Accounts payable and accrued lia...
Operating lease liability
Amortization of premiums and acc...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-09-30
2025-06-30
Total operating expenses
23,701
-
Loss from operations
-23,701
-
Other income, net
981
-
Net loss
-6,611
-16,109
Stock-based compensation
1,410
3,234
Depreciation expense
243
486
Non-cash lease expense
69
132
Amortization of premiums and accretion of discounts on available-for-sale securities, net
70
192
Prepaid expenses and other current and long-term assets, net
-603
-1,164
Accounts payable and accrued liabilities
-207
-10,179
Operating lease liability
-105
-200
Net cash used in operating activities
-4,668
-21,664
Purchases of available-for-sale securities
3,336
16,269
Maturities of available-for-sale securities
8,990
9,359
Net cash (used in) provided by investing activities
5,654
-6,910
Proceeds from issuance of common stock under employee stock purchase plan
0
24
Net cash provided by financing activities
0
24
Net decrease in cash, cash equivalents and restricted cash
986
-28,550
Cash and cash equivalents at beginning of period
49,069
-
Cash and cash equivalents at end of period
21,505
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Maturities of
available-for-sale securities
$8,990K
Net cash (used in)
provided by investing...
$5,654K
Canceled cashflow
$3,336K
Net decrease in
cash, cash...
$986K
Canceled cashflow
$4,668K
Purchases of
available-for-sale securities
$3,336K
Stock-based compensation
$1,410K
Prepaid expenses and
other current and...
-$603K
Depreciation expense
$243K
Non-cash lease expense
$69K
Net cash used in
operating activities
-$4,668K
Canceled cashflow
$2,325K
something is missing
$16,109K
Other income, net
$981K
Net loss
-$6,611K
Canceled cashflow
$17,090K
Accounts payable and
accrued liabilities
-$207K
Operating lease liability
-$105K
Amortization of premiums and
accretion of discounts on...
$70K
Loss from operations
-$23,701K
Total operating
expenses
$23,701K
Buy us a coffee
Athira Pharma, Inc. (ATHA)
Athira Pharma, Inc. (ATHA)